Two functionally distinct pools of vitronectin (Vn) in the blood circulation: Identification of a heparin-binding competent population of Vn within platelet α-granules

Blood

Volumn 88, Issue 2, 1996, Pages 552-560

  Seiffert, Dietmar ^a   Schleef, Raymond R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; MONOCLONAL ANTIBODY; VITRONECTIN;

ARTICLE; CELL GRANULE; CIRCULATION; COMPLEMENT ACTIVATION; CONFORMATIONAL TRANSITION; DISULFIDE BOND; GENE EXPRESSION; HUMAN; HUMAN CELL; LIGAND BINDING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; THROMBOCYTE ACTIVATION;

EID: 0029953975     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.2.552.bloodjournal882552     Document Type: Article

References (41)

1. Preissner KT: Structure and biological role of vitronectin. Annu Rev Cell Biol 7:275, 1991
2. Tomasini BR, Mosher DF: Vitronectin, in Coller BS (ed): Progress in Hemostasis and Thrombosis. Philadelphia, PA, W.B. Saunders, 1990, p 269
3. Jenne D, Stanley KK: Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion. EMBO J 4:3153, 1985
4. Suzuki S, Oldberg A, Hayman EG, Pierschbacher MD, Ruoslahti E: Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J 4:2519, 1985
5. Tomasini BR, Mosher DF: On the identity of vitronectin and S-protein: Immunological crossreactivity and functional studies. Blood 68:737, 1986
6. III CR, Ruoslahti E: Association of thrombin-antithrombin III complexes with vitronectin in serum. J Biol Chem 260:15610, 1985
7. Preissner KT, Mueller-Berghaus G: Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. J Biol Chem 262:12247, 1987
8. Declerk PJ, de Mol M, Alessi M-C, Baudner S, Paques E-P, Preissner KT, Mueller-Berghaus G, Collen D: Purification and characterization of a plasminogen activator inhibitor I binding protein from human plasma: Identification as a multimeric form of S protein (vitronectin). J Biol Chem 263:15454, 1988
9. Seiffert D, Loskutoff DJ: Evidence that type I plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin. J Biol Chem 266:2824, 1991
10. Conlan MG, Tomasini BR, Schultz RL, Mosher DF: Plasma vitronectin polymorphism in normal subjects and patients with disseminated intravascular coagulation. Blood 72:185, 1988
11. Izumi M, Yamada KM, Hayashi M: Vitronectin exists in two structurally and functionally distinct forms in human plasma. Biochim Biophys Acta 990:101, 1989
12. Gebb C, Hayman EG, Engvall E, Ruoslahti E: Interaction of vitronectin with collagen. J Biol Chem 261:16698, 1986
13. Hildebrand A, Preissner KT, Mueller-Berghaus G, Teschemacher H: A novel beta-endorphin binding protein: Complement S protein (=vitronectin) exhibits specific non-opoid binding sites for beta-endorphin upon interaction with heparin or surfaces. J Biol Chem 264:15429, 1989
14. Naski MC, Lawrence DA, Mosher DF, Podor TJ, Ginsburg D: Kinetics of inactivation of alpha-thrombin by plasminogen activator inhibitor-1: Comparison of the effects of native and urea-treated forms of vitronectin. J Biol Chem 268:12367, 1993
15. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA: Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269:32380. 1994
16. Zanetti A, Conforti G, Hess S, Marin-Padura I, Ghibaudi E, Preissner KT, Dejana E: Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membranes. Blood 84:1116, 1994
17. Panetti TS, McKeown-Longo PJ: Receptor-mediated endocytosis of vitronectin is regulated by its conformational state. J Biol Chem 268:11988, 1993
18. Barnes DW, Silnutzer J, See C, Shaffer M: Characterization of human serum spreading factor with monoclonal antibodies. Proc Natl Acad Sci USA 80:1362, 1983
19. Parker CJ, Stone OL, White VF, Bernshaw NJ: Vitronectin (S protein) is associated with platelets. Br J Haematol 71:245, 1989
20. Preissner KT, Holzhueter S, Justus C, Mueller-Berghaus G: Identification and partial characterization of platelet vitronectin: Evidence for complex formation with platelet-derived plasminogen activator inhibitor-1. Blood 74:1989, 1989
21. Stockmann A, Hess S, Declerck P, Timpl R, Preissner KT: Multimeric vitronectin: Identification and characterization of conformation-dependent self-association of the adhesive protein. J Biol Chem 268:22874, 1993
22. Seiffert D, Ciambrone G, Wagner NV, Binder BR, Loskutoff DJ: The somatomedin B domain of vitronectin: Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor. J Biol Chem 269:2659, 1994
23. Tomasini BR, Mosher DJ: Conformational states of vitronectin: Preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexes with thrombin-antithrombin III or treated with urea. Blood 72:903, 1988
24. Seiffert D: Evidence that conformational changes upon the transition of the native to the modified form of vitronectin are not limited to the heparin binding domain. FEBS Lett 368:155, 1995
25. Seiffert D, Loskutoff DJ: Kinetic analysis of the interaction between type 1 plasminogen activator inhibitor and vitronectin and evidence that the bovine inhibitor binds to a thrombin-derived amino-terminal fragment of bovine vitronectin. Biochem Biophys Acta 1078:23, 1991
26. Yatohgo T, Izumi M, Kashiwagi H, Hayashi M: Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Funct 13:281, 1988
27. Ehrlich HJ, Klein Gebbink R, Keijer J, Linders M, Preissner KT, Pannekoek H: Alteration of serpin specificity by a protein cofactor: Vitronectin endows plasminogen activator inhibitor I with thrombin inhibitory properties. J Biol Chem 265:13029, 1990
28. Harlow E, Lane D: Antibodies: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1988
29. Rendu F, Lebret M, Nurden AT, Caen JP: Initial characterization of human platelet mepacrine-labelled granules isolated using a short metrizamide gradient. Br J Haematol 52:241, 1982
30. Gogstad GO: A method for the isolation of alpha-granules from human platelets. Thromb Res 20:669, 1980
31. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
32. Seiffert D, Wagner NN, Loskutoff DJ: Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor. J Cell Biol 111:1283, 1990
33. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD: Molecular Biology of the Cell (ed 2). New York, NY, Garland, 1989
34. Roger M, Halstensen TS, Hogasen K, Mollnes TE, Solum NO, Hovig T: Platelets and vitronectin: Immunohistochemical localization and platelet interaction with exogenously added vitronectin. Nouv Rev Fr Hematol 34:47, 1992
35. Lang IM, Schleef RR: Calcium-dependent stabilization of type 1 plasminogen activator inhibitor within platelet alpha-granules. J Biol Chem 271:2754, 1996
36. Kruithof EKO, Nicolosa G, Bachmann F: Plasminogen activator inhibitor 1 : Development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Blood 70:1645, 1987
37. Eitzman DT, Fay WP, Lawrence DA, Francis-Chmura AM, Shore JD, Olson ST, Ginsburg D: Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro. J Clin Invest 95:2416, 1995
38. Booth NA, Robbie LA, Croll AM, Bennett B: Lysis of platelet-rich thrombi: The role of PAI-1. Ann NY Acad Sci 667:70, 1992
39. Mimuro J, Loskutoff DJ: Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells. J Biol Chem 264:5058, 1989
40. Asch E, Podack E: Vitronectin binds to activated human platelets and plays a role in platelet aggregation. J Clin Invest 85:1372, 1990
41. Leung LLK, Harpel PC, Nachman RL, Rabellino EM: Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood 62:1016, 1983